Skip to main content
CHRS logo

CHRS · Coherus Oncology, Inc. · Documents

Track CHRS — free
$0.37 -0.02 (-4.47%) At close · Nov 20 Play latest call Q3 2026 earnings call transcript
Market Cap
$57.15M
Shares
154.54M
Volume · Nov 20 2.52M Avg daily vol (3M) 1.8M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2022
Feb 23
Annual report 10-K FY2021, ended Dec 31
Annual report for FY2021
Revenue $326.55M ▼ 31.4% Net loss $287.1M Diluted EPS -$3.81
2021
Feb 25
Annual report 10-K FY2020, ended Dec 31
Annual report for FY2020
Revenue $475.82M ▲ 33.6% Net income $132.24M ▲ 47.2% Diluted EPS $1.62 ▲ 31.7%
2020
Nov 5
Quarterly report 10-Q FY2020 Q3, ended Sep 30
Quarterly report for FY2020 Q3
Revenue $113.55M ▲ 1.7% Net income $27.93M Diluted EPS $0.33 ▼ 47.6%
Aug 6
Quarterly report 10-Q FY2020 Q2, ended Jun 30
Quarterly report for FY2020 Q2
Revenue $135.67M ▲ 62.6% Net income $59.03M Diluted EPS $0.70 ▲ 118.8%
Showing 151–200 of 205 documents
Key facts CIK 1512762 CUSIP 19249H103 13F (30d) 150 filings 120 filers Visit website Investor relations